CY1122640T1 - Θεραπεια και προφυλαξη δερματιτιδας ακτινοβολιας - Google Patents

Θεραπεια και προφυλαξη δερματιτιδας ακτινοβολιας

Info

Publication number
CY1122640T1
CY1122640T1 CY20191100866T CY191100866T CY1122640T1 CY 1122640 T1 CY1122640 T1 CY 1122640T1 CY 20191100866 T CY20191100866 T CY 20191100866T CY 191100866 T CY191100866 T CY 191100866T CY 1122640 T1 CY1122640 T1 CY 1122640T1
Authority
CY
Cyprus
Prior art keywords
treatment
radiation dermatitis
prevention
dermatitis
radiation
Prior art date
Application number
CY20191100866T
Other languages
English (en)
Inventor
Mark Lait
George Bishop
Original Assignee
Water-Jel Europe Llp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Water-Jel Europe Llp filed Critical Water-Jel Europe Llp
Publication of CY1122640T1 publication Critical patent/CY1122640T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Η παρούσα αποκάλυψη αφορά σε τοπικά σκευάσματα που περιλαμβάνουν καθαρό ύδωρ, υγρό πρωτεΐνης γάλακτος και πυκνωτικό, ιδιαιτέρως υδρογέλη και λοσιόν και χρήση αυτών στη θεραπεία δερματίτιδας ακτινοβολίας, ιδιαιτέρως σε μία διεργασία δύο σταδίων για τη θεραπεία δερματίτιδας ακτινοβολίας.
CY20191100866T 2013-03-06 2019-08-13 Θεραπεια και προφυλαξη δερματιτιδας ακτινοβολιας CY1122640T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361773225P 2013-03-06 2013-03-06
GB201304041A GB201304041D0 (en) 2013-03-06 2013-03-06 Treatment and prophylaxis of radiation dermatitis
PCT/EP2014/054319 WO2014135622A2 (en) 2013-03-06 2014-03-06 Treatment and prophylaxis of radiation dermatitis

Publications (1)

Publication Number Publication Date
CY1122640T1 true CY1122640T1 (el) 2021-03-12

Family

ID=48142536

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20191100866T CY1122640T1 (el) 2013-03-06 2019-08-13 Θεραπεια και προφυλαξη δερματιτιδας ακτινοβολιας

Country Status (18)

Country Link
US (3) US10098912B2 (el)
EP (1) EP2964248B1 (el)
CN (1) CN105120882A (el)
AU (1) AU2014224619B2 (el)
CA (1) CA2903647C (el)
CY (1) CY1122640T1 (el)
DK (1) DK2964248T3 (el)
ES (1) ES2742851T3 (el)
GB (1) GB201304041D0 (el)
HK (1) HK1218722A1 (el)
HR (1) HRP20191490T1 (el)
HU (1) HUE045730T2 (el)
LT (1) LT2964248T (el)
PL (1) PL2964248T3 (el)
PT (1) PT2964248T (el)
RS (1) RS59160B1 (el)
SI (1) SI2964248T1 (el)
WO (1) WO2014135622A2 (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD863671S1 (en) 2015-10-07 2019-10-15 William James Reimann Water pipe
CN105796831A (zh) * 2016-04-19 2016-07-27 北京欣普迪生物科技有限公司 医用射线防护剂及其制备方法
DE102018201598A1 (de) * 2018-02-02 2019-08-08 Beiersdorf Ag Stabile Wundheilsalbe
CN116157387A (zh) 2020-07-16 2023-05-23 德玛万科学有限公司 异喹啉化合物及其在治疗AhR失衡中的用途
CN114191597B (zh) * 2021-12-16 2022-11-25 湖南银华棠医药科技有限公司 一种皮肤创面修复用液体敷料及其制备方法和用途

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69618968T2 (de) * 1995-08-31 2002-11-28 Procter & Gamble Hautpflegemittel. das silikongummi sowie eine mischung aus polyoxiethylenen und einer glycerinverbindung enthalt
US5736128A (en) * 1996-05-14 1998-04-07 Isp Investments Inc. Cosmetic composition for rejuvenation of skin without skin irritation
US20020006913A1 (en) * 1997-11-04 2002-01-17 Von Borstel Reid W. Antimutagenic compositions for treatment and prevention of photodamage to skin
KR100885948B1 (ko) * 2002-07-02 2009-02-26 주식회사 포스코 래이들 경동스탠드 새들의 슬래그 제거장치
KR100500172B1 (ko) * 2002-10-02 2005-07-07 주식회사 대웅 사람 표피성장인자 및 락토카인을 포함하는 피부 보호용화장료 조성물
WO2005042828A2 (en) * 2003-11-03 2005-05-12 Ciba Specialty Chemicals Holding Inc. Stabilized body care products, household products, textiles and fabrics
DE102004003436A1 (de) * 2004-01-21 2005-08-11 Beiersdorf Ag Dünnflüssige O/W-Emulsion II
US20050175559A1 (en) * 2004-02-10 2005-08-11 Pcr Technology Holdings, Lc Method and preparation for reducing skin hyperpigmentation
EP1865920A1 (en) 2005-04-04 2007-12-19 Bioartificial Gel Technologies Inc. Prevention and treatment of radiation dermatitis
US20070248555A1 (en) * 2006-04-20 2007-10-25 Watson Dana M Composition and method for managing redness of skin associated with dermatological condition
EP2049135A4 (en) 2006-06-22 2009-12-30 Agennix Inc LACTOFERRINE AS RADIOPROTECTIVE AGENT
US9192558B2 (en) * 2006-12-15 2015-11-24 The Procter & Gamble Company Skin care compositions
FR2937866B1 (fr) * 2008-10-30 2010-11-26 Natura Cosmeticos Sa Complexe antioxydant, compositions cosmetiques et pharmaceutiques contenant ledit complexe et utilisation dudit complexe
GB0822823D0 (en) * 2008-12-15 2009-01-21 Dow Corning Silicone oi-in-water emulsions
ES2354098B1 (es) * 2009-08-12 2012-01-31 Jose Andres Prieto Alonso Preparado líquido de afeitado.
FR2950054B1 (fr) * 2009-09-16 2011-10-07 Chanel Parfums Beaute Composition cosmetique comprenant un derive de leucodopachrome
EP2533753B1 (en) * 2009-11-10 2022-07-06 Laboratory Skin Care, Inc. Sunscreen compositions comprising uniform, rigid, spherical, nanoporous calcium phosphate particles, and methods of making and using the same
US9629856B2 (en) * 2010-03-03 2017-04-25 Anteis Sa Compositions and methods for the treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds
WO2012057895A2 (en) * 2010-10-26 2012-05-03 Quinnova Pharmaceuticals, Inc. Composition and method for treating wounds
US20130209378A1 (en) * 2012-02-09 2013-08-15 The Dial Corporation Skin conditioning and lubricating creme, and method of making and using same

Also Published As

Publication number Publication date
AU2014224619A1 (en) 2015-10-08
EP2964248A2 (en) 2016-01-13
US10098912B2 (en) 2018-10-16
CA2903647C (en) 2020-06-23
CN105120882A (zh) 2015-12-02
CA2903647A1 (en) 2014-09-12
HUE045730T2 (hu) 2020-01-28
WO2014135622A2 (en) 2014-09-12
HRP20191490T1 (hr) 2019-11-15
AU2014224619B2 (en) 2018-03-22
US20180264042A1 (en) 2018-09-20
DK2964248T3 (da) 2019-08-26
GB201304041D0 (en) 2013-04-17
PT2964248T (pt) 2019-09-04
WO2014135622A3 (en) 2014-10-30
LT2964248T (lt) 2019-09-10
RS59160B1 (sr) 2019-10-31
EP2964248B1 (en) 2019-05-22
PL2964248T3 (pl) 2019-11-29
HK1218722A1 (zh) 2017-03-10
US11850265B2 (en) 2023-12-26
US20160015752A1 (en) 2016-01-21
US20210008116A1 (en) 2021-01-14
SI2964248T1 (sl) 2019-10-30
ES2742851T3 (es) 2020-02-17

Similar Documents

Publication Publication Date Title
CY1122640T1 (el) Θεραπεια και προφυλαξη δερματιτιδας ακτινοβολιας
ZA201509363B (en) Water treatment process and water treatment system.
ES2765949T8 (es) Terapia que involucra anticuerpos contra la claudina 18.2 para el tratamiento del cáncer
CL2015003704A1 (es) Péptidos y peptidomiméticos en usos de combinación y tratamientos para la subpoblacion de pacientes con cáncer
CL2016002243A1 (es) Un método, dispositivo y sistema para desplegar tendencias y variación en un grupode datos fisiológicos.
EA201400178A1 (ru) Лечение рака молочной железы
PT2848097T (pt) Dispositivo para o tratamento de plasma de superfícies humanas, animais ou de plantas, em particular da pele ou de áreas de membrana mucosa
FR3029779B1 (fr) Composition cosmetique comprenant des olefine sulfonates lineaires, des tensioactifs anioniques non oxyalkylenes, et des tensioactifs non ioniques et/ou amphoteres, et procede de traitement cosmetique
DK3411491T3 (da) Produkthåndtering i biologisk omdannelsesproces
BR112016018170A2 (pt) métodos para tratar doença de alzheimer
DK2764881T3 (da) System til medicinsk behandling
BR112015005369A2 (pt) inibidores de usp30 e métodos para sua utilização
TR201910866T4 (tr) Kanser tedavisi için birleşik preparasyonlar.
FR3029778B1 (fr) Composition cosmetique comprenant des alpha-olefine sulfonates lineaires, des tensioactifs anioniques et des tensioactifs non ioniques et/ou ampho-teres, et procede de traitement cosmetique
EA201692284A1 (ru) Ниацинамид для стимуляции продуцирования антимикробных пептидов
TR201901348T4 (tr) Metap-2 inhibitörleri olarak pirolidinon türevleri.
EA201590503A1 (ru) Альфа-1-микроглобулин для применения в лечении заболеваний, связанных с митохондриями
ITUB20152355A1 (it) Dispositivo di illuminazione, ad esempio per l'illuminazione di serre, e corrispondente procedimento di impiego
EA201792123A1 (ru) Лечение боли
IL246290A0 (en) Process, device and system for water treatment
TR201905218T4 (tr) Nörodejenerati̇f hastaliklarin tedavi̇si̇ i̇çi̇n yararli vi̇tanoli̇dler.
EA201590615A1 (ru) Стимулирующие лактацию композиции на основе фосфатидилсерина
FR3030270B1 (fr) Procede de traitement cosmetique et kit associe
CY1119212T1 (el) Χρηση του odiparcil στη θεραπεια μιας μυκοπολυσακχαριδωσης
UY34667A (es) ?método y dispositivo para el tratamiento de trastornos del colesterol en la sangre?.